![](https://investorshub.advfn.com/uicon/442676.png?cb=1490264709)
Monday, April 21, 2014 2:19:47 PM
Alzatrex, Targeted to Assist Those With Memory Deficits and to Reduce Brain Fog From MMJ Use
"Alzatrex"™, an herbal supplement that may be taken orally that combines medical cannabis with a proprietary formula of herbal COX-2 inhibitors. Research has shown that ?9-THC, the main active ingredient in medical marijuana, decreases ß-amyloid plaques and neurodegeneration in Alzheimer's disease, and that it is reduced further by the addition of a COX-2 inhibitor. A COX-2 inhibitor is a form of NSAID that is used to reduce pain.
FACTS
-Alzheimer's disease is the sixth leading cause of death in the United States.
-More than 5 million Americans are living with the disease.
-In 2013, Alzheimer's will cost the nation $203 billion. This number is expected to rise to $1.2 trillion by 2050.
The "Big Pharma" companies are gonna be pissed !! ...hahahaha
http://finance.yahoo.com/news/sk3-groups-berkeley-bio-organic-131500763.html
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM